HomeAPPH • ETR
add
Apontis Pharma AG
Previous close
€8.32
Day range
€8.00 - €8.28
Year range
€3.03 - €11.85
Market cap
70.72M EUR
Avg Volume
8.37K
P/E ratio
-
Dividend yield
-
Primary exchange
ETR
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 8.95M | -33.85% |
Operating expense | 7.85M | -0.83% |
Net income | -3.89M | -2,405.26% |
Net profit margin | -43.46 | -3,576.80% |
Earnings per share | — | — |
EBITDA | -1.85M | -263.11% |
Effective tax rate | 23.06% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 26.82M | -26.22% |
Total assets | 57.46M | -4.00% |
Total liabilities | 27.20M | 48.72% |
Total equity | 30.26M | — |
Shares outstanding | 8.33M | — |
Price to book | 2.29 | — |
Return on assets | -10.12% | — |
Return on capital | -16.02% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -3.89M | -2,405.26% |
Cash from operations | -1.81M | -159.63% |
Cash from investing | -934.96K | -90.42% |
Cash from financing | 3.00M | 722.91% |
Net change in cash | 256.02K | -87.58% |
Free cash flow | -1.98M | -2,217.74% |
About
Founded
1946
Website
Employees
177